ArticleAnnals of translational medicine2022

Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review.

Mei-Na Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.